Matrix metalloproteinases in the CNS: interferons get nervous

Sameeksha Chopra1,2, Christopher M Overall3,4, Antoine Dufour5,6

  • 1Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.

Insights

Matrix metalloproteinases (MMPs) have dual roles in inflammation, impacting extracellular matrix and immune signaling. Recent research reveals their complex functions in central nervous system (CNS) diseases, with both detrimental and protective effects.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) traditionally linked to extracellular matrix (ECM) degradation in inflammation.
  • Disappointing clinical trials prompted re-evaluation of MMP roles.
  • Emerging evidence highlights novel functions in viral infections and autoimmune diseases.

Purpose of the Study:

  • To explore the multifaceted roles of MMPs beyond ECM degradation.
  • To investigate the beneficial and destructive functions of MMPs in central nervous system (CNS) pathologies.
  • To discuss therapeutic strategies involving MMP inhibitors.

Main Methods:

  • Review of recent scientific literature on MMPs in inflammation and CNS diseases.
  • Analysis of MMPs' proteolytic processing of immune signaling molecules (chemokines, cytokines).
  • Examination of MMPs' substrate cleavage within the CNS.

Main Results:

  • MMPs regulate immune responses through chemokine and cytokine processing, affecting signaling pathways.
  • MMPs cleave CNS substrates, contributing to both disease promotion and dampening.
  • Over 10 MMPs exhibit protective functions, challenging the initial view of solely pathological roles.

Conclusions:

  • MMPs possess diverse functions in CNS pathologies, extending beyond ECM degradation.
  • Understanding the dual roles of MMPs is crucial for developing targeted therapies.
  • MMP inhibitors offer potential therapeutic strategies for CNS inflammatory diseases.